1 completed, 1 terminated. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Cytoki Pharma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CK-0045 Proof-of-concept Study in Participants With Overweight / Obesity and Type 2 Diabetes CK-0045, Placebo - Type 2 Diabetes Mellitus (T2DM), Obesity and Overweight | Phase 2 | Terminated | Cytoki Pharma | 90 | 2024-09-06 | 2026-02-20 |
| A Phase 1 Study to Investigate Safety, Tolerability, and Pharmacokinetics of CK-0045 in Healthy Participants and Otherwise Healthy Participants With Obesity CK-0045, Placebo - Healthy | Phase 1 | Completed | Cytoki Pharma | 76 | 2022-12-26 | 2024-01-10 |
Diabetes Mellitus, Type 2 (1) · Obesity (1) · Overweight (1)
Belgium (1) · Germany (1)
Lotte Verwillingen, MD (1) · Tim Heise, MD (1)